Prof. Dr. A Taha
WUC Malaysia & CDU China, New Zealand
Title: Genetic Polymorphism and CRISPR Technologies: Paving the Way for Future Therapies
Abstract:
Recent advances in genetic polymorphism and gene editing technologies have
opened up exciting opportunities for research and development. With the
continued progress in these areas, we can look forward to a future where genetic
diseases can be diagnosed and treated more effectively, ultimately improving
the quality of life for millions of people worldwide. In this presentation, I
will be focusing on the recent advances in genetic polymorphism and how gene
editing and CRISPR technologies are shaping the future of genetic research. I
will discuss the recent developments in understanding gene expression and the
role it plays in genetic polymorphisms. Additionally, I will highlight the
recent progress in gene editing technologies, including the development of new
CRISPR systems and their applications in treating genetic diseases. Finally, I
will discuss the future prospects of gene editing and CRISPR technologies,
including the ethical considerations and the challenges that lie ahead.
Biography:
Prof. Dr. A Taha is a Visiting Professor
and External Advisor from New Zealand, and a High-end Foreign Expert at WUC Malaysia
& CDU China. Research interests include biomedical engineering, genetic
polymorphism effective delivery for genes in vitro, gene knock in and genomic
screening, and various topics related to biomedical research. the research
results have been published in more than 50 papers in international journals
and conferences, including various sci/scie/ieee indexing. received various
awards such as chosen for who’s who in medicine and Healthcare 2010. Currently an
editorial board member for several international journals.
Prof. Dr. A Taha, MSc,
PhD
Auckland, New Zealand |
MMC Reg. No. 74494
ORCID:
https://orcid.org/0000-0003-3831-2459
Scopus Author ID: 57201420645
Web of Science ResearcherID: AAN-4913-2020; Google
Scholar Prof Dr. Ahmad Taha Khalaf.